checkAd

     2152  0 Kommentare Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $100,000 Investing in Marrone Bio Innovations, Inc. (MBII) to Contact the Firm

    NEW YORK, NY--(Marketwired - September 05, 2014) - Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Marrone Bio Innovations, Inc. ("Marrone" or the "Company") (NASDAQ: MBII) of the November 4, 2014 deadline to seek the role of lead plaintiff in a federal securities class action lawsuit filed against Marrone and certain executives.

    A complaint has been filed in the Eastern District of California on behalf of all persons who purchased or otherwise acquired Marrone securities between March 6, 2014 through September 2, 2014, inclusive (the "Class Period").

    The complaint alleges that the Company and its executives violated federal securities laws with respect to its disclosures concerning its business, operations, and prospects.

    Specifically, the action alleges that during the Class Period, Marrone made false and/or misleading statements and/or failed to disclose that: (i) there were errors regarding improper revenue recognition in the Company's financial statements; and (ii) Marrone did not employ adequate internal controls concerning its financial reporting.

    On September 3, 2014, the Company disclosed that, among other things, some of its previously issued financial statements should no longer be relied upon as being compliant with generally accepted accounting principles.

    Following this news, the price of Marrone stock declined by $2.50, or over 44%, to close at $3.15 on September 3, 2014.

    Request more information now by clicking here: www.faruqilaw.com/MBII. There is no cost or obligation to you.

    Take Action

    If you invested in Marrone stock or options between March 6, 2014 through September 2, 2014, and would like to discuss your legal rights, visit www.faruqilaw.com/MBII. You can also contact us by calling Richard Gonnello toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to rgonnello@faruqilaw.com. Faruqi & Faruqi, LLP also encourages anyone with information regarding Marrone's conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

    Faruqi & Faruqi, LLP is a national law firm which represents investors and individuals in class action litigation. The firm is focused on providing exemplary legal services in complex litigation in the areas of securities, shareholder, antitrust and consumer litigation, throughout all phases of litigation. The firm has an experienced trial team which has achieved significant victories on behalf of the firm's clients. To keep track of the latest securities litigation news, follow us on Twitter at www.twitter.com/MergerActivity or on Facebook at www.facebook.com/FaruqiLaw.

    Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.

    FARUQI & FARUQI, LLP
    369 Lexington Avenue, 10th Floor
    New York, NY 10017
    Attn: Richard Gonnello, Esq.
    rgonnello@faruqilaw.com
    Telephone: (877) 247-4292 or (212) 983-9330





    Verfasst von Marketwired
    Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $100,000 Investing in Marrone Bio Innovations, Inc. (MBII) to Contact the Firm NEW YORK, NY--(Marketwired - September 05, 2014) - Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Marrone Bio Innovations, Inc. ("Marrone" or the "Company") (NASDAQ: MBII) of the November 4, 2014 deadline to seek …